Medifast, Inc. (MED) DCF Valuation

Medifast, Inc. (MED) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

Medifast, Inc. (MED) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Evaluate Medifast, Inc.'s (MED) financial outlook like an expert! This (MED) DCF Calculator comes with pre-filled financial data and offers complete flexibility to modify revenue growth, WACC, margins, and other essential assumptions to align with your projections.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 713.7 934.8 1,526.1 1,598.6 1,072.1 1,241.8 1,438.5 1,666.2 1,930.1 2,235.7
Revenue Growth, % 0 30.99 63.25 4.75 -32.94 15.84 15.84 15.84 15.84 15.84
EBITDA 95.7 134.2 223.1 201.8 139.5 168.9 195.7 226.6 262.5 304.1
EBITDA, % 13.4 14.35 14.62 12.63 13.01 13.6 13.6 13.6 13.6 13.6
Depreciation 4.6 7.3 11.9 17.1 13.1 11.2 12.9 15.0 17.4 20.1
Depreciation, % 0.64792 0.77767 0.77853 1.07 1.22 0.89901 0.89901 0.89901 0.89901 0.89901
EBIT 91.0 126.9 211.2 184.8 126.4 157.7 182.7 211.7 245.2 284.0
EBIT, % 12.76 13.57 13.84 11.56 11.79 12.7 12.7 12.7 12.7 12.7
Total Cash 92.7 174.5 109.5 87.7 150.0 144.8 167.8 194.3 225.1 260.7
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 1.4 .6 .0 .0 .0
Account Receivables, % 0.20135 0.06247045 0 0 0
Inventories 48.8 53.4 180.0 118.9 54.6 91.6 106.1 122.9 142.3 164.9
Inventories, % 6.83 5.71 11.8 7.44 5.09 7.37 7.37 7.37 7.37 7.37
Accounts Payable 22.6 36.1 70.9 53.1 39.2 46.3 53.7 62.2 72.0 83.4
Accounts Payable, % 3.17 3.86 4.65 3.32 3.66 3.73 3.73 3.73 3.73 3.73
Capital Expenditure -10.1 -5.9 -34.2 -16.7 -6.5 -14.7 -17.1 -19.8 -22.9 -26.5
Capital Expenditure, % -1.41 -0.62973 -2.24 -1.04 -0.60473 -1.19 -1.19 -1.19 -1.19 -1.19
Tax Rate, % 22.81 22.81 22.81 22.81 22.81 22.81 22.81 22.81 22.81 22.81
EBITAT 76.8 97.2 160.3 144.1 97.6 123.7 143.3 166.0 192.2 222.7
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF 43.8 108.3 46.7 187.9 154.5 89.6 131.9 152.8 177.0 205.0
WACC, % 9.28 9.25 9.24 9.25 9.25 9.26 9.26 9.26 9.26 9.26
PV UFCF
SUM PV UFCF 565.5
Long Term Growth Rate, % 0.50
Free cash flow (T + 1) 206
Terminal Value 2,353
Present Terminal Value 1,511
Enterprise Value 2,077
Net Debt -72
Equity Value 2,149
Diluted Shares Outstanding, MM 11
Equity Value Per Share 196.81

What You Will Get

  • Pre-Filled Financial Model: Medifast’s actual data allows for accurate DCF valuation.
  • Full Forecast Control: Modify revenue growth, profit margins, WACC, and other essential drivers.
  • Instant Calculations: Automatic updates provide real-time results as adjustments are made.
  • Investor-Ready Template: A polished Excel file crafted for high-quality valuation.
  • Customizable and Reusable: Designed for adaptability, enabling repeated use for comprehensive forecasts.

Key Features

  • 🔍 Real-Life MED Financials: Pre-filled historical and projected data for Medifast, Inc. (MED).
  • ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
  • 📊 Professional DCF Valuation: Built-in formulas calculate Medifast’s intrinsic value using the Discounted Cash Flow method.
  • ⚡ Instant Results: Visualize Medifast’s valuation instantly after making changes.
  • Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.

How It Works

  • Download: Obtain the pre-prepared Excel file containing Medifast, Inc.'s (MED) financial information.
  • Customize: Modify projections, including sales growth, EBITDA %, and WACC.
  • Update Automatically: The intrinsic value and NPV calculations refresh in real-time.
  • Test Scenarios: Develop various forecasts and instantly compare the results.
  • Make Decisions: Leverage the valuation findings to inform your investment approach.

Why Choose This Calculator for Medifast, Inc. (MED)?

  • Comprehensive Tool: Features DCF, WACC, and financial ratio analyses tailored for Medifast, Inc. (MED).
  • Customizable Inputs: Modify yellow-highlighted cells to explore different financial scenarios.
  • Detailed Insights: Automatically computes Medifast, Inc. (MED)'s intrinsic value and Net Present Value.
  • Preloaded Data: Access historical and forecasted data to ensure accurate analysis.
  • Professional Quality: Perfect for financial analysts, investors, and consultants focused on Medifast, Inc. (MED).

Who Should Use This Product?

  • Individual Investors: Make informed decisions about buying or selling Medifast, Inc. (MED) stock.
  • Financial Analysts: Streamline valuation processes with ready-to-use financial models tailored for Medifast, Inc. (MED).
  • Consultants: Deliver professional valuation insights on Medifast, Inc. (MED) to clients quickly and accurately.
  • Business Owners: Understand how companies like Medifast, Inc. (MED) are valued to guide your own business strategy.
  • Finance Students: Learn valuation techniques using real-world data and scenarios related to Medifast, Inc. (MED).

What the Template Contains

  • Preloaded MED Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
  • DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
  • Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
  • Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
  • Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
  • Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.

No products were found matching.